Whereas 50% of patients with LIMA1 high tumor succumbed in less than 3 years, the patients with LIMA1 low tumor did not reach the 50% mortality even after 5-year follow-up (Fig. 1B, red dashed line). The gene discussed is LIMA1; the disease is neoplasm.